Companies
why Relay Therapeutics Inc [RLAY] is a Good Choice for Investors After New Price Target of $23.05
Relay Therapeutics Inc [NASDAQ: RLAY] slipped around -0.1 points on Thursday, while shares priced at $6.11 at the close of the session, down -1.61%. Compared to the average trading volume of 1.14M shares, RLAY reached a trading volume of 2901447 in the most recent trading
